What's in NHS Greater Glasgow and Clyde's pipeline?

NHS Greater Glasgow and Clyde has 8 drugs in our index: 3 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 2 in Phase 1.

Which companies overlap with NHS Greater Glasgow and Clyde's portfolio?

Top competitors by shared drug class: Central Hospital, Nancy, France, Eurofarma Laboratorios S.A., Farma de Colombia SA, Genentech, Inc., Grupo Argentino de Tratamiento de la Leucemia Aguda.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nhs-greater-glasgow-and-clyde.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

NHS Greater Glasgow and Clyde — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

NHS Greater Glasgow and Clyde pipeline: 3 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 2 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Olumiant	Olumiant	marketed		Casein kinase I isoform gamma-1, Citron Rho-interacting kinase, Mitogen-activated protein kinase kinase kinase 1	Immunology
Inhaled Tiotropium	Inhaled Tiotropium	marketed
Metolazone Tablets	Metolazone Tablets	marketed	Thiazide-like diuretic	Na-Cl cotransporter (NCC)	Cardiovascular
Intravenous Tenecteplase	Intravenous Tenecteplase	phase 3	Fibrinolytic agent / Tissue plasminogen activator (tPA)	Plasminogen / Fibrin	Cardiovascular

Therapeutic area mix

Cardiovascular · 2
Immunology · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Central Hospital, Nancy, France · 1 shared drug class
Eurofarma Laboratorios S.A. · 1 shared drug class
Farma de Colombia SA · 1 shared drug class
Genentech, Inc. · 1 shared drug class
Grupo Argentino de Tratamiento de la Leucemia Aguda · 1 shared drug class
Hospices Civils de Lyon · 1 shared drug class
Hospital Clinic of Barcelona · 1 shared drug class
Ascentage Pharma Group Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for NHS Greater Glasgow and Clyde:

Cite this brief

Drug Landscape (2026). NHS Greater Glasgow and Clyde — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nhs-greater-glasgow-and-clyde. Accessed 2026-05-18.